A group of investors filed a lawsuit against Selena Gomez alleging fraud related to her mental health startup, claiming she failed to deliver on promises to build and market the company. The plaintiffs invested nearly $1.2 million in the venture, according to court filings.
The lawsuit centers on Gomez's role as a founder and figurehead in the startup, with investors arguing that she misrepresented her level of involvement and commitment to the business. The plaintiffs contend that Gomez did not fulfill obligations tied to product development, market expansion, or her personal participation in growing the company as represented during fundraising.
The exact name of the startup and the timing of when the lawsuit was filed remain central details. However, the case highlights tensions that can emerge when celebrity investors or founders take equity stakes in early-stage companies without hands-on operational involvement. Investors expect founders to deliver on explicit commitments, whether those involve time allocation, strategic direction, or brand amplification.
Gomez's involvement in mental health startups aligns with her public advocacy around mental wellness and her documented personal struggles with anxiety and depression. Celebrity-backed health and wellness ventures have proliferated in recent years, with varying degrees of founder commitment ranging from active daily participation to purely advisory or brand-licensing arrangements.
The lawsuit raises questions about due diligence practices when vetting celebrity founders. Investors often face pressure to back entrepreneurs with recognizable names and established platforms, but celebrity status does not guarantee operational capacity or sustained engagement. The case also illustrates how misaligned expectations between founders and investors about job responsibilities can escalate into legal disputes.
Gomez has built a significant business portfolio beyond music and acting. She previously co-founded Rare Beauty, a cosmetics brand, which demonstrated her ability to operate a successful consumer brand. However, scaling a mental health technology company presents entirely different challenges than beauty retail, requiring clinical expertise, regulatory navigation, and consumer trust in digital health services.
The mental health startup space has attracted considerable venture capital in recent years, with companies focused on therapy delivery, meditation apps, and psychiatric care platforms raising substantial rounds. Competitors in this space typically employ clinical advisors, licensed therapists, and experienced health tech operators to navigate the complex regulatory and operational landscape.
The outcome of this lawsuit could have broader implications for how celebrity investors and founders structure their involvement in startups. It may push future agreements to include more explicit performance metrics, milestone-based equity vesting, or reduced equity stakes when founders plan limited operational involvement. Legal precedent around founder liability and investor protections in celebrity-backed ventures remains relatively limited, making this case potentially instructive for both investors and entertainment personalities considering startup involvement.